{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T05:28:21Z","timestamp":1790832501894,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.carrev.2019.04.002","type":"journal-article","created":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T18:50:49Z","timestamp":1554403849000},"page":"15-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"S","title":["Hemorrhagic Cardiac Tamponade Associated with Apixaban: A Case Report and Systematic Review of Literature"],"prefix":"10.1016","volume":"20","author":[{"given":"Zain Ul Abideen","family":"Asad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sardar Hassan","family":"Ijaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amna Mohyud Din","family":"Chaudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safi U.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneesh","family":"Pakala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.carrev.2019.04.002_bb0005","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.carrev.2019.04.002_bb0010","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.carrev.2019.04.002_bb0015","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1200\/JCO.2014.59.7351","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: American society of clinical oncology clinical practice guideline update 2014","volume":"33","author":"Lyman","year":"2015","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.carrev.2019.04.002_bb0020","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1056\/NEJMra022643","article-title":"Acute cardiac tamponade","volume":"349","author":"Spodick","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.carrev.2019.04.002_bb0025","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"151","author":"Liberati","year":"2009","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.carrev.2019.04.002_bb0030","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.hrcr.2017.11.015","article-title":"First reported case series in the United States of hemopericardium in patients on apixaban","volume":"4","author":"Sablani","year":"2018","journal-title":"HeartRhythm Case Rep"},{"issue":"2","key":"10.1016\/j.carrev.2019.04.002_bb0035","first-page":"1","article-title":"Acute haemorrhagic tamponade in cancer patients receiving direct oral anticoagulant: case series","volume":"1","author":"Tracy Nassif","year":"2017","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.carrev.2019.04.002_bb0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s11739-017-1736-3","article-title":"Cardiac tamponade due to apixaban therapy in patient with unknown pericardial hemangioma","volume":"13","author":"Sbrana","year":"2018","journal-title":"Intern Emerg Med"},{"issue":"7","key":"10.1016\/j.carrev.2019.04.002_bb0045","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1002\/phar.1602","article-title":"Spontaneous Hemopericardium in a patient receiving Apixaban therapy: first case report","volume":"35","author":"Sigawy","year":"2015","journal-title":"Pharmacotherapy."},{"key":"10.1016\/j.carrev.2019.04.002_bb0050","article-title":"A rare case of spontaneous cardiac tamponade induced by concomitant use of rivaroxaban and amiodarone","volume":"2018","author":"Oladiran","year":"2018","journal-title":"Case Rep Cardiol"},{"issue":"12","key":"10.1016\/j.carrev.2019.04.002_bb0055","first-page":"1491","article-title":"Ibrutinib-Associated Atrial Fibrillation","volume":"4","author":"Ganatra","year":"2018","journal-title":"JACC: Clin. Electrophysiol."},{"key":"10.1016\/j.carrev.2019.04.002_bb0060","series-title":"Life-threatening hemopericardium associated with rivaroxaban","author":"Basnet","year":"2017"},{"issue":"1","key":"10.1016\/j.carrev.2019.04.002_bb0065","article-title":"Rivaroxaban and Hemopericardium \u2013 is there an association?","volume":"2","author":"Gowani","year":"2017","journal-title":"Austin Cardio Cardiovas Case Rep"},{"key":"10.1016\/j.carrev.2019.04.002_bb0070","unstructured":"Rhew SH, Kim SS. Hemorrhagic pericarditis associated with rivaroxaban in an atrial fibrillation patient with pacemaker."},{"issue":"4","key":"10.1016\/j.carrev.2019.04.002_bb0075","doi-asserted-by":"crossref","first-page":"e1128","DOI":"10.1097\/MJT.0000000000000263","article-title":"Spontaneous, life-threatening hemorrhagic cardiac tamponade secondary to rivaroxaban","volume":"23","author":"Kham","year":"2016","journal-title":"Am J Ther"},{"key":"10.1016\/j.carrev.2019.04.002_bb0080","doi-asserted-by":"crossref","unstructured":"Menendez D, Michel J. Hemopericardium with tamponade following rivaroxaban administration and its attenuation by CYP3A4 inhibitors. Proceedings (Baylor University Medical Center) 2016;29(4):414\u2013415.","DOI":"10.1080\/08998280.2016.11929492"},{"issue":"7","key":"10.1016\/j.carrev.2019.04.002_bb0085","first-page":"206","article-title":"Cardiac Tamponade Associated with Rivaroxaban","volume":"87","author":"Boone","year":"2015","journal-title":"Del Med J"},{"key":"10.1016\/j.carrev.2019.04.002_bb0090","series-title":"Isolated hemopericardium associated with rivaroxaban: First case report","author":"Shivamurthy","year":"2014"},{"key":"10.1016\/j.carrev.2019.04.002_bb0095","doi-asserted-by":"crossref","unstructured":"Xu B, MacIsaac A. Life-threatening haemorrhagic pericarditis associated with rivaroxaban. 2014.","DOI":"10.1016\/j.ijcard.2014.04.151"},{"key":"10.1016\/j.carrev.2019.04.002_bb0100","series-title":"Dabigatran-induced spontaneous hemopericardium and cardiac tamponade","author":"Jelani","year":"2017"},{"key":"10.1016\/j.carrev.2019.04.002_bb0105","series-title":"Hemopericardium and cardiac tamponade in a patient treated with dabigatran etexilate","author":"Kizilirmak","year":"2016"},{"key":"10.1016\/j.carrev.2019.04.002_bb0110","series-title":"Spontaneous hemopericardium with dabigatran etexilate","author":"Masoomi","year":"2015"},{"key":"10.1016\/j.carrev.2019.04.002_bb0115","series-title":"Hemopericardium under dabigatran for stroke prevention in atrial fibrillation","author":"Stollberger","year":"2017"},{"issue":"3","key":"10.1016\/j.carrev.2019.04.002_bb0120","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.hrtlng.2015.02.006","article-title":"A sanguineous pleuro pericardial effusion in a patient recently treated with dabigatran","volume":"44","author":"Abdallah","year":"2015","journal-title":"Heart & Lung"},{"issue":"5","key":"10.1016\/j.carrev.2019.04.002_bb0125","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1002\/j.1875-9114.2012.01036.x","article-title":"Hemopericardium in a patient treated with dabigatran etexilate","volume":"32","author":"Barton","year":"2012","journal-title":"Pharmacotherapy."},{"issue":"7\u20138","key":"10.1016\/j.carrev.2019.04.002_bb0130","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1345\/aph.1R112","article-title":"Hemopericardium and cardiac tamponade associated with dabigatran use","volume":"46","author":"Dy","year":"2012","journal-title":"Ann Pharmacother"},{"issue":"9","key":"10.1016\/j.carrev.2019.04.002_bb0135","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3109\/15563650.2012.721888","article-title":"Hemorrhagic complications associated with dabigatran use","volume":"50","author":"Chen","year":"2012","journal-title":"Clin Toxicol (Phila)"},{"issue":"5","key":"10.1016\/j.carrev.2019.04.002_bb0140","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003476","volume":"10","author":"Katz","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"9","key":"10.1016\/j.carrev.2019.04.002_bb0145","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/bcp.13299","article-title":"Trends in the prescription of novel oral anticoagulants in UK primary care","volume":"83","author":"Loo","year":"2017","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.carrev.2019.04.002_bb0150","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00277-015-2566-x","article-title":"How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation","volume":"95","author":"Schaefer","year":"2016","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.carrev.2019.04.002_bb0155","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/cncy.21790","article-title":"Diagnostic yield of cytopathology in evaluating pericardial effusions: Clinicopathologic analysis of 419 specimens","volume":"125","author":"Saab","year":"2017","journal-title":"Cancer Cytopathol"},{"issue":"3","key":"10.1016\/j.carrev.2019.04.002_bb0160","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/(SICI)1097-0339(199609)15:3<197::AID-DC5>3.0.CO;2-E","article-title":"Diagnostic accuracy of pericardial fluid cytology: an analysis of 53 specimens from 44 consecutive patients","volume":"15","author":"Malamou-Mitsi","year":"1996","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.carrev.2019.04.002_bb0165","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijcard.2014.12.062","article-title":"Pericardial bleeding risk with non-vitamin K oral anticoagulants: a meta-analysis","volume":"182","author":"Caldeira","year":"2015","journal-title":"Int J Cardiol"},{"issue":"16","key":"10.1016\/j.carrev.2019.04.002_bb0170","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","article-title":"The 2018 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"39","author":"Steffel","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.carrev.2019.04.002_bb0175","series-title":"Hemopericardium and cardiac tamponade associated with dabigatran use","author":"Dy","year":"2012"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919302283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838919302283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:16:21Z","timestamp":1761560181000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838919302283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":35,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S1553838919302283"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2019.04.002","relation":{},"ISSN":["1553-8389"],"issn-type":[{"value":"1553-8389","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hemorrhagic Cardiac Tamponade Associated with Apixaban: A Case Report and Systematic Review of Literature","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2019.04.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}